A Randomized, Double-blind, Placebo-controlled Pilot Study of Suvorexant for Insomnia in Parkinson Disease (P11-5.005)

To explore safety & efficacy of suvorexant for insomnia in Parkinson disease and to assess viability of a larger study.

Authors

Institutions

Publication Details

Journal
Neurology
Published
2025-04-07
DOI
https://doi.org/10.1212/wnl.0000000000208595
Citations
1
Primary Topic
Sleep and related disorders
Type
article
Field-Weighted Citation Impact
2.12
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Randomized, Double-blind, Placebo-controlled Pilot Study of Suvorexant for Insomnia in Parkinson Disease (P11-5.005)

Raymond Park, Daniel Burdick, Alen Delic, Pinky Agarwal et al.
1 citations
Neurology
Sleep and related disorders
2.12
article

A Randomized, Double-blind, Placebo-controlled Pilot Study of Suvorexant for Insomnia in Parkinson Disease (P11-5.005)

Raymond Park, Daniel Burdick, Alen Delic, Pinky Agarwal, Maria Cardona-Gonzalez
article en
1 citations

Abstract

To explore safety & efficacy of suvorexant for insomnia in Parkinson disease and to assess viability of a larger study.

NeurologyVol. 104(7_Supplement_1)
EvergreenHealth (US), Biostatistical Consulting (United States) (US), Evergreen Health Medical Center (US)
Good health and well-being
Openalex Percentile: Top 15%
Sleep and related disorders
2.12
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.